Literature DB >> 16951739

Curcumin induces cell death without oligonucleosomal DNA fragmentation in quiescent and proliferating human CD8+ cells.

Adriana Magalska1, Agnieszka Brzezinska, Anna Bielak-Zmijewska, Katarzyna Piwocka, Grazyna Mosieniak, Ewa Sikora.   

Abstract

UNLABELLED: Cytotoxic CD8+ cells play an important role in determining host response to tumor, thus chemotherapy is potentially dangerous as it may lead to T cells depletion. The purpose of this study was to elucidate the propensity of quiescent and proliferating human CD8+ cells to undergo cell death upon treatment with curcumin, a natural dye in Phase I of clinical trials as a prospective chemopreventive agent.
METHODS: We treated human quiescent or proliferating CD8+ cells with 50 microM curcumin or irradiated them with UVC. Cell death symptoms such as decreased cell viability, chromatin condensation, activation of caspase-3 and specific DFF40/CAD endonuclease and oligonucleosomal DNA fragmentation were analyzed using MTT test, microscopic observation, Western blotting and flow cytometry.
RESULTS: Curcumin decreased cell viability, activated caspase-3 and decreased the level of DFF45/ICAD, the inhibitor of the DFF40/CAD endonuclease. However, this did not lead to oligonucleosomal DNA degradation. In contrast, UVC-irradiated proliferating, but not quiescent CD8+ cells revealed molecular and morphological changes characteristic for apoptosis, including oligonucleosomal DNA fragmentation. Curcumin can induce cell death in normal human lymphocytes both quiescent and proliferating, without oligonucleosomal DNA degradation which is considered as a main hallmark of apoptotic cell death. Taking into account the role of CD8+ cells in tumor response, their depletion during chemotherapy could be particularly undesirable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951739

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  11 in total

1.  Antiproliferation and apoptosis on RKO colon cancer by Millingtonia hortensis.

Authors:  Siwapong Tansuwanwong; Hiroyuki Yamamoto; Kohzoh Imai; Usanee Vinitketkumnuen
Journal:  Plant Foods Hum Nutr       Date:  2009-03       Impact factor: 3.921

2.  Curcumin disrupts meiotic and mitotic divisions via spindle impairment and inhibition of CDK1 activity.

Authors:  A Bielak-Zmijewska; M Sikora-Polaczek; K Nieznanski; G Mosieniak; A Kolano; M Maleszewski; J Styrna; E Sikora
Journal:  Cell Prolif       Date:  2010-08       Impact factor: 6.831

Review 3.  Curcumin and cancer cells: how many ways can curry kill tumor cells selectively?

Authors:  Jayaraj Ravindran; Sahdeo Prasad; Bharat B Aggarwal
Journal:  AAPS J       Date:  2009-07-10       Impact factor: 4.009

Review 4.  Prevention and treatment of cancers by immune modulating nutrients.

Authors:  Naveena B Janakiram; Altaf Mohammed; Venkateshwar Madka; Gaurav Kumar; Chinthalapally V Rao
Journal:  Mol Nutr Food Res       Date:  2016-03-09       Impact factor: 5.914

5.  Demethoxycurcumin Retards Cell Growth and Induces Apoptosis in Human Brain Malignant Glioma GBM 8401 Cells.

Authors:  Tzuu-Yuan Huang; Che-Wen Hsu; Weng-Cheng Chang; Miin-Yau Wang; June-Fu Wu; Yi-Chiang Hsu
Journal:  Evid Based Complement Alternat Med       Date:  2012-02-15       Impact factor: 2.629

6.  Curcuminoid binding to embryonal carcinoma cells: reductive metabolism, induction of apoptosis, senescence, and inhibition of cell proliferation.

Authors:  Wolfgang W Quitschke
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

Review 7.  Immunosuppressive Effects of Natural α,β-Unsaturated Carbonyl-Based Compounds, and Their Analogs and Derivatives, on Immune Cells: A Review.

Authors:  Laiba Arshad; Ibrahim Jantan; Syed Nasir Abbas Bukhari; Md Areeful Haque
Journal:  Front Pharmacol       Date:  2017-01-30       Impact factor: 5.810

Review 8.  Curcumin and Osteosarcoma: Can Invertible Polymeric Micelles Help?

Authors:  Avudaiappan Maran; Michael J Yaszemski; Ananiy Kohut; Andriy Voronov
Journal:  Materials (Basel)       Date:  2016-06-27       Impact factor: 3.623

9.  Curcumin in cell death processes: a challenge for CAM of age-related pathologies.

Authors:  S Salvioli; E Sikora; E L Cooper; C Franceschi
Journal:  Evid Based Complement Alternat Med       Date:  2007-04-23       Impact factor: 2.629

10.  Concurrent inhibition of enzymatic activity and NF-Y-mediated transcription of Topoisomerase-IIα by bis-DemethoxyCurcumin in cancer cells.

Authors:  S Belluti; V Basile; P Benatti; E Ferrari; G Marverti; C Imbriano
Journal:  Cell Death Dis       Date:  2013-08-08       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.